M. Samuelson

发表

Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis.

Meredith Y. Smith, F. Richy, Meritxell Sabidó-Espin, 2015, Journal of managed care & specialty pharmacy.